Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t ... view more

RSS Sort By :
TITLE Price Buy Now More options

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H1 2017, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


Notes: Sales, means the sales volume of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies Schizophrenia Drug in China market, focuses on the top players in China market, with capa...

$ 3200


Notes: Sales, means the sales volume of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies sales (consumption) of Schizophrenia Drug in Europe market, especially in Germany, France...

$ 3900


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H1 2017, provides an overview of the Cognitive Impairment Associated With Schizophrenia (...

$ 2000


Notes: Sales, means the sales volume of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies sales (consumption) of Schizophrenia Drug in United States market, focuses on the top pla...

$ 3800


Notes: Production, means the output of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies Schizophrenia Drug in Global market, especially in North America, Europe, China, Japan, So...

$ 2900


DelveInsight’s Schizophrenia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Schizophrenia for the seven major markets i.e. United States, EU5 (France, Germany, Ita...

$ 4950


DelveInsight “Schizophrenia - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Schizophrenia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and f...

$ 2750


DelveInsight’s Report, “Schizophrenia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe....

$ 2000


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized by several symptom domains including positive symptoms (such as hallucinations or delusions and disorganized...

$ 10995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. GlobalData has released its pharma report, "Schizophrenia - Current and Future Players". The report is a vital source ...

$ 2995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disor...

$ 4995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disor...

$ 6995


*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disor...

$ 4995


Schizophrenia is a severe mental disorder that affects an individual’s behaviors, thoughts, and emotions; it is extremely heterogeneous, and no two affected individuals have the same experience (Buckley et al., 2009). The disorder is charact...

$ 3995


Notes: Production, means the output of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies Schizophrenia Drug in Global market, especially in North America, Europe, China, Japan, So...

$ 3500


GlobalData's clinical trial report, "Schizophrenia Global Clinical Trials Review, H2, 2016" provides an overview of Schizophrenia clinical trials scenario. This report provides top line data relating to the clinical trials on Schizophrenia. Report...

$ 2500


Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H2, 2016 Summary GlobalData''s clinical trial report, “Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials ...

$ 2500


Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape. The report provid...

$ 2000

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: